Moderna Inc.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

72.21%

Market Cap

16.37 Bil.

P/E Ratio

0.00

Dividend Yield

0.00 %

Earnings per Share

-6.43 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE40.785 G0 Units
PRICE DETERMINATION TIME06/10/2026 / 10:33:26 AM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW41.1240.705
PREV. DAY'S PRICE41.26 (06/09)
CHANGE DAY BEFORE
-0.48
-1.15 %
52 WEEK HIGH / LOW51.01 (03/04)19.402 (11/21)
More Price Information

Key Figures (in EUR)

2027e2026e202520242023
EARNINGS PER SHARE-4.27-7.51-6.43-8.57-11.41
DIVIDENDS PER SHARE0.000.000.000.000.00
DIVIDEND YIELD IN %--0.00 %0.00 %0.00 %
DIVIDEND GROWTH IN %-----
PRICE - EARNINGS RATIO-----
PRICE - BOOK RATIO--1.341.472.74
PRICE - SALES RATIO--5.904.935.55
PRICE - CASH FLOW RATIO-----
Further Key Figures

Master Data

WKN
A2N9D9
ISIN
US60770K1079
SYMBOL
0QF
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
MODERNA INC. DL-,0001
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
US Dollar
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
396.79 Mil.
MARKET CAPITALISATION
16.37 Bil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
5.07 %
-10.26 %
-13.40 %
75.48 %
72.21 %
-64.03 %
-76.86 %
56.05 %
HIGH44.7650.3550.3551.0151.01155.96431.4551.01
LOW38.9538.0038.0023.7419.4019.4019.4025.24
Dividend
per share
MODERNA INC. DL-,0001 does not deliver dividend information

Company profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.